Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcean Harvest T Regulatory News (OHT)

Share Price Information for Ocean Harvest T (OHT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.25
Bid: 15.00
Ask: 15.50
Change: 0.00 (0.00%)
Spread: 0.50 (3.333%)
Open: 15.25
High: 15.25
Low: 15.25
Prev. Close: 15.25
OHT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trial Updates

19 Jun 2023 07:00

RNS Number : 0768D
Ocean Harvest Technology Group PLC
19 June 2023
 

19 June 2023

 

Ocean Harvest Technology Group plc

 

("OHT", the "Company", or the "Group")

 

Feed Trial Results update

 

 

Ocean Harvest Technology Group plc, a leading global producer of animal feed supplements from multispecies seaweed blends, is pleased to announce the results from four recently completed feed trials. The first three trials were carried out by universities in conjunction with potential customers whilst the swine trial was undertaken directly by a potential customer.

 

Highlights:

· A laying hen trial confirmed improvements in both egg production and feed efficiency when birds were fed an OceanFeedTM Poultry supplemented diet. These performance improvements materially increased income per hen.

· A catfish trial demonstrated that fish fed with OceanFeedTM Aqua in their diets had higher feed intake and weight gain, leading to a substantial increase in final weight.

· A trial with juvenile shrimp where OceanFeedTM Aqua improved both weight gain and feed efficiency, thus reducing production costs. OceanFeedTM Aqua also helped reduce mortality in a disease challenge trial run in parallel.

· A commercial swine trial reported material improvements in feed efficiency in piglets with OceanFeedTM Swine included in their diet. OceanFeedTM Swine successfully replaced a combination of seven conventional gut health additives. 

 

These results add to the Company's substantive dataset demonstrating the efficacy of OceanFeedTM in improving animal performance across a range of species, and highlights the important benefits of using OceanFeedTM ingredients in a number of applications. The substantial and growing breadth of data across multiple species is helpful in driving new customer adoption which remains an important aspect of OHT's revenue growth. More details on these results are available in the trial report summaries on the company's website, www.oceanharvesttechnology.com.

 

 

Mark Williams, CEO, Ocean Harvest Technology, commented:

"We are delighted that these trials have again demonstrated the benefits of Ocean Harvest's OceanFeed™ products. Our proprietary seaweed blends are delivering strong results in animal performance and production economics in a cost-effective and environmentally sustainable manner. OHT will continue to invest in developing our product portfolio, and we are confident that the significant benefits of our products will support future customer growth."

 

 

 

 

Investor Presentation via Investor Meet Company

 

Ocean Harvest Technology is pleased to announce Dr Hadden Graham, Chief Commercial Officer and Dr Ian Hutchinson, Technical Director will provide a live presentation about the Company's Trial Programmes via Investor Meet Company on 26th June 2023 at 2:00pm BST.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Ocean Harvest Technology via:

https://www.investormeetcompany.com/ocean-harvest-technology-group-plc/register-investor

Investors who already follow the Company on the Investor Meet Company platform will automatically be invited.

 

For more information please contact:

Ocean Harvest Technology Group plc

Tel: +44 (0)118 228 7612

 

 

Mark Williams, CEO

 

 

 

 

finnCap Ltd (Nominated Adviser and Sole Broker)

Tel: +44 020 7220 0500

Geoff Nash / Seamus Fricker / George Dollemore (Corporate Finance)

 

Charlotte Sutcliffe / Harriet Ward (ECM)

 

 

 

Camarco (Financial PR Adviser)

Tel: +44 (0) 203 757 4991

Tom Huddart / Rosie Driscoll / Letaba Rimell

oht@camarco.co.uk

 

 

 

 

Notes to Editors

 

Ocean Harvest Technology Group plc is a global leader in the development and commercialisation of value adding products from multiple species of seaweed. The Company provides a range of natural ingredients focused on improving animal performance whilst protecting the environment, through its unique and proven intellectual property portfolio. The Company's products are produced in its facility in Vietnam from seaweeds soured from multiple markets across the world.

For more information, please visit www.oceanharvesttechnology.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDNKFBDCBKDFAD
Date   Source Headline
25th Apr 20243:54 pmRNSResult of AGM
17th Apr 20247:00 amRNSGrant of Options
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20247:00 amRNSFinal Results and Notice of AGM
14th Mar 20247:00 amRNSNotice of Results and Investor Presentation
8th Mar 20247:00 amRNSChange of Registered Office
27th Feb 20247:00 amRNSGrant of Patent
26th Jan 20247:00 amRNSNotification of upcoming investor presentation
24th Jan 20247:00 amRNSDirector/PDMR Shareholding
23rd Jan 20247:00 amRNSTrading Update, Board Changes and New Hires
27th Nov 20234:39 pmRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSAppointment of CFO
2nd Nov 20237:00 amRNSStrong Performance of OceanFeed in poultry trial
31st Oct 20239:58 amRNSInvestor Presentation via Investor Meet Company
22nd Sep 20234:55 pmRNSDirector/PDMR Shareholding
19th Sep 20234:12 pmRNSDirector/PDMR Shareholding
12th Sep 20234:54 pmRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Results and Results Presentation
17th Jul 20235:08 pmRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSTrading Update and Notice of Results
7th Jul 20237:00 amRNSDirector/PDMR Dealing
29th Jun 20232:31 pmRNSDirector/PDMR Shareholding
26th Jun 20231:33 pmRNSDirector/PDMR Shareholding
23rd Jun 20234:14 pmRNSResult of AGM
19th Jun 20237:00 amRNSTrial Updates
5th Jun 20232:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSNotice of AGM
26th May 202312:01 pmRNSDirector/PDMR Shareholding
25th May 20237:00 amRNSBoard Change and Posting of Annual Results
27th Apr 20235:38 pmRNSnotification of major holdings
26th Apr 20237:00 amRNSAppointment to the Board
24th Apr 20237:42 amRNSDirector/PDMR Shareholding
19th Apr 20234:09 pmRNSHolding(s) in Company
18th Apr 20235:45 pmRNSDirector/PDMR Shareholding
18th Apr 20237:00 amRNSHolding(s) in Company
14th Apr 20234:58 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSInvestor Presentation
5th Apr 20237:00 amRNSDirector/PDMR Shareholding
4th Apr 20237:00 amRNSAdmission to Trading on AIM
4th Jun 200812:00 pmRNSCancellation of Admission
29th May 20087:45 amRNS1st Quarter Results
1st May 20088:30 amRNSNotice of Special Meeting
10th Mar 20087:45 amRNSRe Contract
3rd Mar 20087:45 amRNSAnnual Report and Accounts
12th Feb 20087:45 amRNSRe Contract
28th Jan 20087:45 amRNSRe. Contract
14th Jan 20087:45 amRNSRe Contract
8th Jan 20087:45 amRNSStaff Appointments
3rd Jan 200810:45 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.